A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sulindac | CAS 38194-50-2 - Request Quote

Picture of Sulindac
SZ CAT No:SZ-S060001
CAS No
38194-50-2
Mol.F.
C20H17FO3S
Mol.Wt.
356.4
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sulindac is chemically [(1Z)-6-Fluoro-3-[[4-[(RS)-methanesulfinyl]phenyl]methylidene]-2-methyl-3H-inden-1-yl]acetic acid (as per EP) ; 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl) phenyl]methylene]-, (Z)- ;(as per USP). Sulindac is supplied with detailed characterization data compliant with regulatory guideline. Sulindac can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sulindac.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 38194-50-2

Purchase 38194-50-2

Order 38194-50-2

Enquire 38194-50-2

price of 38194-50-2

38194-50-2 Supplier

38194-50-2 Manufacturer

38194-50-2 Exporter

buy high quality Sulindac

Purchase Sulindac

Sulindac suppliers

Sulindac manufacturers

Sulindac price

Order Sulindac

Enquire Sulindac

Sulindac cost

Sulindac Supplier

Sulindac Distributor

Sulindac for Method Validation

Sulindac Reference Standard

Sulindac for ANDA Filing

Sulindac for Forced Degradation Studies

Sulindac Identification Standards

Sulindac for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,